Issue 2/2017
Content (13 Articles)
Hepatitis B (J Lim, Section Editor)
Management of Chronic Hepatitis B in Children
Danielle Wendel, Karen F. Murray
Hepatitis B (J Lim, Section Editor)
Clinical Implications and Management of Chronic Occult Hepatitis B Virus Infection
Mohit Mittal, Ke-Qin Hu
Hepatitis B (J Lim, Section Editor)
Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B Infection
Anthony W.H. Chan, Grace L.H. Wong, Vincent W.S. Wong
Hepatitis B (J Lim, Section Editor)
Ethnic Disparities in Chronic Hepatitis B Infection: African Americans and Hispanic Americans
Kimberly A. Forde
Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)
Autoimmune Hepatitis: When Is It Safe to Stop Therapy, or Withhold Therapy Altogether?
Christina Weiler-Normann, Johannes Hartl, Ansgar W. Lohse
Open Access
Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)
Why Doesn’t Primary Biliary Cholangitis Respond to Immunosuppressive Medications?
Antonio Molinaro, Hanns-Ulrich Marschall
Open Access
Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)
Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?
Roger W Chapman, Kate D. Williamson
Autoimmune, Cholestatic, and Biliary Diseases (S Gordon and C Bowlus, Section Editors)
The Causes and Clinical Spectrum of Drug-Induced Cholestatic Liver Injury
Lara Dakhoul, Raj Vuppalanchi
Hepatic Cancer (A Singal and A Mufti, Section Editors)
Should AFP (or Any Biomarkers) Be Used for HCC Surveillance?
Hager F. Ahmed Mohammed, Lewis R. Roberts
Hepatic Cancer (A Singal and A Mufti, Section Editors)
Multidisciplinary Team Management of Patients with Hepatocellular Carcinoma
Caitlin A. Hester, Ali A. Mokdad, Adam C. Yopp
Open Access
Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)
Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?
Hannes Hagström
Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)
Portal Vein Thrombosis and Cirrhosis: The Role of Anticoagulation
Andrea Mancuso
Management of the Cirrhotic Patient (A Cardenas and N Reau, Section Editors)
Biomarkers and Liver Disease: Can We Predict Decompensation with suPAR?
Alexander Koch, Frank Tacke